Evidence map›Paper›PMID 31949126›Full record

ArticleCell death & disease2020

Drp1-mediated mitochondrial fission promotes renal fibroblast activation and fibrogenesis.

Yating Wang, Miaoqing Lu, Liping Xiong, Jinjin Fan, Yi Zhou, Huiyan Li, Xuan Peng, Zhong Zhong, Yihan Wang, Fengxian Huang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 128 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Yating Wang *Department of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Miaoqing Lu *NHC Key Laboratory of Nephrology, Guangzhou, China.
Liping Xiong *Department of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Jinjin FanDepartment of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yi ZhouDepartment of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Huiyan LiDepartment of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Xuan PengDepartment of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Zhong ZhongDepartment of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yihan WangLaboratory for Kidney Pathology, Inc., Nashville, TN, USA.
Fengxian HuangDepartment of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Wei ChenDepartment of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Xueqing YuDepartment of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Haiping MaoDepartment of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. maohp@mail.sysu.edu.cn.
The First Affiliated Hospital, Sun Yat-sen University · CNSun Yat-sen University · CNKey Laboratory of Guangdong Province · CNKidney Associates · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excessive mitochondrial fission acts as a pro-proliferative marker in some cancers and organ fibrosis; its potential role in renal fibroblast activation and fibrogenesis has never been investigated. Here, we showed more pronounced fragmented mitochondria in fibrotic than in non-fibrotic renal fibroblast in humans and mice. In a mouse model of obstructive nephropathy, phosphorylation of Drp1 at serine 616 (p-Drp1S616) and acetylation of H3K27(H3K27ac) was increased in fibrotic kidneys; pharmacological inhibition of mitochondrial fission by mdivi-1 substantially reduced H3K27ac levels, fibroblasts accumulation, and interstitial fibrosis. Moreover, mdivi-1 treatment was able to attenuate the established renal fibrosis. In cultured renal interstitial fibroblasts, targeting Drp1 using pharmacological inhibitor or siRNA suppressed TGF-β1-elicited cell activation and proliferation, as evidenced by inhibiting expression of α-smooth muscle actin (α-SMA) and collagen I, as well as by reducing DNA synthesis. In contrast, Drp1 deletion enhanced cell apoptosis, along with decreased mitochondrial fragmentation, mtROS elevation, and glycolytic shift upon TGF-β1 stimulation. In Drp1 deletion fibroblasts, re-expression of wild-type Drp1 rather than Drp1S616A mutant restores the reduction of TGF-β-induced-Drp1 phosphorylation, H3K27ac, and cell activation. Moreover, TGF-β1 treatment increased the enrichment of H3K27ac at the promoters of α-SMA and PCNA, which was reversed in Drp1-knockdown fibroblasts co-transfected with empty vector or Drp1S616A, but not wild-type Drp1. Collectively, our results imply that inhibiting p-Drp1S616-mediated mitochondrial fission attenuates fibroblast activation and proliferation in renal fibrosis through epigenetic regulation of fibrosis-related genes transcription and may serve as a therapeutic target for retarding progression of chronic kidney disease.

Indexed as

Mitochondrial DynamicsAnimalsApoptosisCell ProliferationDynaminsFibroblastsFibrosisGene Knockdown TechniquesHistonesHumansKidneyLysineMaleMice, Inbred C57BLMitochondriaPhosphorylationDnm1l protein, mouseDnm1l protein, ratDynaminsHistonesLysinePhosphoserineProliferating Cell Nuclear AntigenReactive Oxygen SpeciesTransforming Growth Factor beta1

Identifiers

PMID31949126
PMCPMC6965618
OpenAlexW2998904270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.